Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
2.490
-0.220 (-8.12%)
May 20, 2025, 4:00 PM EDT
Propanc Biopharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.05 | 0.02 | 0.01 | 0 | 0 | 0.07 | Upgrade
|
| Cash & Short-Term Investments | 0.05 | 0.02 | 0.01 | 0 | 0 | 0.07 | Upgrade
|
| Cash Growth | 715.82% | 109.86% | 147.04% | 80.36% | -96.64% | 2698.96% | Upgrade
|
| Other Receivables | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Prepaid Expenses | 9.68 | 0 | 0.01 | 0.01 | - | - | Upgrade
|
| Total Current Assets | 9.74 | 0.03 | 0.02 | 0.02 | 0.01 | 0.07 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.02 | 0.04 | 0.06 | 0 | 0.03 | Upgrade
|
| Long-Term Deferred Charges | 0.09 | 0.03 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 12.7 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 22.53 | 0.07 | 0.06 | 0.08 | 0.01 | 0.1 | Upgrade
|
| Accounts Payable | 1.12 | 1.21 | 0.97 | 0.94 | 1 | 0.84 | Upgrade
|
| Accrued Expenses | 1.87 | 1.53 | 1.21 | 0.94 | 1.31 | 1.06 | Upgrade
|
| Short-Term Debt | 1.15 | 0.87 | 0.51 | 0.98 | 0.68 | 1.61 | Upgrade
|
| Current Portion of Leases | 0 | 0.02 | 0.02 | 0.02 | - | 0.03 | Upgrade
|
| Other Current Liabilities | 0.19 | 0.16 | 0.45 | 0.18 | 0.09 | 0.21 | Upgrade
|
| Total Current Liabilities | 4.34 | 3.79 | 3.16 | 3.06 | 3.08 | 3.74 | Upgrade
|
| Long-Term Debt | 0.09 | 0.06 | - | - | - | - | Upgrade
|
| Long-Term Leases | - | - | 0.02 | 0.04 | - | - | Upgrade
|
| Total Liabilities | 4.44 | 3.85 | 3.18 | 3.11 | 3.08 | 3.74 | Upgrade
|
| Common Stock | 0.01 | 0.48 | 0.01 | 0 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 138.21 | 61.22 | 60.31 | 57.36 | 54.07 | 50.91 | Upgrade
|
| Retained Earnings | -121.55 | -66.7 | -64.68 | -61.56 | -58.2 | -55.78 | Upgrade
|
| Treasury Stock | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | Upgrade
|
| Comprehensive Income & Other | 1.46 | 1.27 | 1.29 | 1.21 | 1.09 | 1.27 | Upgrade
|
| Total Common Equity | 18.09 | -3.78 | -3.12 | -3.03 | -3.07 | -3.65 | Upgrade
|
| Shareholders' Equity | 18.09 | -3.78 | -3.12 | -3.02 | -3.07 | -3.64 | Upgrade
|
| Total Liabilities & Equity | 22.53 | 0.07 | 0.06 | 0.08 | 0.01 | 0.1 | Upgrade
|
| Total Debt | 1.25 | 0.95 | 0.55 | 1.04 | 0.68 | 1.63 | Upgrade
|
| Net Cash (Debt) | -1.2 | -0.93 | -0.54 | -1.04 | -0.68 | -1.57 | Upgrade
|
| Filing Date Shares Outstanding | - | 0.01 | - | - | - | - | Upgrade
|
| Working Capital | 5.39 | -3.77 | -3.14 | -3.05 | -3.07 | -3.67 | Upgrade
|
| Tangible Book Value | 18.09 | -3.78 | -3.12 | -3.03 | -3.07 | -3.65 | Upgrade
|
| Machinery | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.